Abstract
Earlier studies have demonstrated the interaction between ADD1 and ACE in relation to arterial properties. We investigated whether arterial characteristics might also be related to interactions of ADD1 with other renin–angiotensin system genes. Using a family-based sampling frame, we randomly recruited 1064 Flemish subjects (mean age, 43.6 years; 50.4% women). By means of a wall-tracking ultrasound system, we measured the properties of the carotid, femoral and brachial arteries. In multivariate-adjusted analyses, we assessed the multiple gene effects of ADD1 (Gly460Trp), AGT (C–532T and G–6A) and AT1R (A1166C). In ADD1 Trp allele carriers, but not in ADD1 GlyGly homozygotes (P-value for interaction ⩽0.014), femoral cross-sectional compliance was significantly higher (0.74 vs 0.65 mm2 kPa−1; P=0.020) in carriers of the AT1R C allele than in AT1R AA homozygotes, with a similar trend for femoral distensibility (11.3 vs 10.2 × 10−3 kPa−1; P=0.055). These associations were independent of potential confounding factors, including age. Family-based analyses confirmed these results. Brachial diameter (4.35 vs 4.18 mm) and plasma renin activity (PRA) (0.23 vs 0.14 ng ml−1 h−1) were increased (P⩽0.005) in AGT CG haplotype homozygotes compared with non-carriers, whereas the opposite was true for brachial distensibility (12.4 vs 14.4 × 10−3 kPa−1; P=0.011). There was no interaction between AGT and any other gene in relation to the measured phenotypes. ADD1 and AT1R interactively determine the elastic properties of the femoral artery. There is a single-gene effect of the AGT promoter haplotypes on brachial properties and PRA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI et al. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-μ2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 2004; 95: 1100–1108.
Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L et al. Hypertension-associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97: 2815–2822.
Bianchi G, Ferrari P, Staessen JA . Adducin polymorphism. Detection and impact on hypertension and related disorders. Hypertension 2005; 45: 331–340.
Staessen JA, Wang J-G, Bianchi G, Birkenhäger WH . Essential hypertension. Lancet 2003; 361: 1629–1641.
Balkestein EJ, Wang J-G, Struijker-Boudier HAJ, Barlassina C, Bianchi G, Birkenhäger WH et al. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens 2002; 20: 1551–1561.
Balkestein EJ, Staessen JA, Wang J-G, van der Heijden-Spek J, Van Bortel LM, Barlassina C et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001; 38: 1190–1197.
Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T . Angiotensin-converting enzyme I/D and α-adducin Gly460Trp polymorphisms. From angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension 2007; 49: 1291–1297.
Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsky J et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7: 215–224.
Zebekakis PE, Nawrot T, Thijs L, Balkestein EJ, van der Heijden-Spek J, Van Bortel LM et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005; 23: 1839–1846.
Seidlerova J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M et al. Association between arterial properties and renal sodium handling in a general population. Hypertension 2006; 48: 609–615.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1): S5–S10.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Van Bortel LM, Balkestein EJ, van der Heijden-Spek J, Vanmolkot FH, Staessen JA, Kragten JA et al. Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001; 19: 1037–1044.
Hoeks AP, Reneman RS . Biophysical principles of vascular diagnosis. J Clin Ultrasound 1995; 23: 71–79.
Kool MJF, van Merode T, Reneman RS, Hoeks APG, Struijker-Boudier HA, Van Bortel LM . Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 1994; 28: 610–614.
Staessen JA, Wang J-G, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19: 1349–1358.
Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S et al. Genotype–phenotype relationships for the renin–angiotensin–aldosterone system in a normal population. Hypertension 1999; 34: 423–429.
Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279–292.
Abdollahi MR, Lewis RM, Gaunt TR, Cumming DVE, Rodriguez S, Rose-Zerilli M et al. Quantitated transcript haplotypes (QTH) of AGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186:A>C), and relevance to metabolic syndrome traits. Hum Mutat 2007; 28: 365–373.
Orlov SN, Adragna NC, Adarichev VA, Hamet P . Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol 1999; 276: C511–C536.
Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786–1797.
Brand E, Chatelain N, Paillard F, Tiret L, Visvikis S, Lathrop M et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 2002; 10: 715–723.
Kuznetsova T, Staessen JA, Reineke T, Olszanecka A, Ryabikov A, Tikhonoff V et al. Context-dependency of the relation between left ventricular mass and AGT gene variants. J Hum Hypertens 2005; 19: 155–163.
Resnick LM, Catanzaro D, Sealey JE, Laragh JH . Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin–aldosterone system. Am J Hypertens 2004; 17: 203–208.
Safar ME, Levy BI, Struijker-Boudier H . Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864–2869.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.
Acknowledgements
This study would not have been possible without the voluntary collaboration of the participants. The municipality Hechtel-Eksel provided logistic support. We acknowledge the expert technical assistance of Sandra Covens, Linda Custers, Marie-Jeanne Jehoul, Hanne Truyens and Ya Zhu (Studies Coordinating Centre, Leuven, Belgium). The European Project on Genes in Hypertension (EPOGH) is endorsed by the European Council for Cardiovascular Research and the European Society of Hypertension. Research included in this report was supported by the European Union (grants IC15-CT98-0329-EPOGH, LSMH-CT-2006-037093 InGenious HyperCare and HEALTH-F4-2007-201550 HyperGenes); the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0424.03, G.02.56.05 and G.0575.06); the Katholieke Universiteit Leuven, Belgium (OT/00/25 and OT/05/49); the Czech Society of Hypertension; the Ministero Universitá e Ricerca Scientifica of Italy (PRIN Grant 2006065339_01); and the Else Kröner-Fresenius Stiftung (P27/05//A24/05//F01). EB is supported by a Heisenberg Professorship from the Deutsche Forschungsgemeinschaft (Br 1589/8-1).
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Seidlerová, J., Staessen, J., Nawrot, T. et al. Arterial properties in relation to genetic variation in α-adducin and the renin–angiotensin system in a White population. J Hum Hypertens 23, 55–64 (2009). https://doi.org/10.1038/jhh.2008.113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.113
Keywords
This article is cited by
-
Do level and variability of systolic blood pressure predict arterial properties or vice versa?
Journal of Human Hypertension (2014)